We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In an address to a joint session of Congress, US President Donald Trump outlined his goal of speeding up FDA approval of new drugs, calling the current process "slow and burdensome."